It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Nearly all patients with small cell lung cancer (SCLC) eventually relapse with chemoresistant disease. The molecular mechanisms driving chemoresistance in SCLC remain un-characterized. Here, we describe whole-exome sequencing of paired SCLC tumor samples procured at diagnosis and relapse from 12 patients, and unpaired relapse samples from 18 additional patients. Multiple somatic copy number alterations, including gains in ABCC1 and deletions in MYCL, MSH2, and MSH6, are identifiable in relapsed samples. Relapse samples also exhibit recurrent mutations and loss of heterozygosity in regulators of WNT signaling, including CHD8 and APC. Analysis of RNA-sequencing data shows enrichment for an ASCL1-low expression subtype and WNT activation in relapse samples. Activation of WNT signaling in chemosensitive human SCLC cell lines through APC knockdown induces chemoresistance. Additionally, in vitro-derived chemoresistant cell lines demonstrate increased WNT activity. Overall, our results suggest WNT signaling activation as a mechanism of chemoresistance in relapsed SCLC.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA
2 Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Alvin J Siteman Cancer Center, Washington University, St. Louis, MO, USA
3 McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA
4 Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Alvin J Siteman Cancer Center, Washington University, St. Louis, MO, USA; Saint Luke’s Health System, Kansas City, MO, USA
5 Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Alvin J Siteman Cancer Center, Washington University, St. Louis, MO, USA; ICCE Institute, Washington University School of Medicine, St. Louis, MO, USA
6 Alvin J Siteman Cancer Center, Washington University, St. Louis, MO, USA
7 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
8 Department of Oncological Sciences, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA
9 Intermountain Healthcare BioRepository and Department of Pathology, Intermountain Healthcare, Salt Lake City, UT, USA
10 McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA; Alvin J Siteman Cancer Center, Washington University, St. Louis, MO, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA; Nationwide Children’s Hospital, Columbus, OH, USA
11 McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Alvin J Siteman Cancer Center, Washington University, St. Louis, MO, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA